Search

everythinglearnresearchcommunity

for

Search:↓

Matrix effects in LC-MS can be managed but not completely avoided.

EPDS and MS might share an immune-related cause.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Nail loss may be a side effect of the MS drug teriflunomide.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Hair loss linked to higher heart disease risk in both men and women.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

People with early hair loss may have higher insulin levels and a greater chance of developing metabolic syndrome.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Deer antler velvet serum helps hair grow and is safe for skin.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Researchers created a new method to measure brain steroids, finding higher levels of certain steroids and changes due to a drug.

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

People with androgenetic alopecia (hair loss) may have a higher risk of developing metabolic syndrome.

Inhibiting class I HDACs helps maintain hair growth ability in skin cells.

Adding yeast extract and methyl jasmonate to Eclipta alba cell cultures increased the production of the compound wedelolactone.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Researchers made two new compounds that could be used for medicine.

Early hair loss may be linked to metabolic syndrome.

High YKL-40 levels predict early hair loss and hidden metabolic issues.